Clinical-stage BioTech Solvonis has acquired Toronto-based Awakn, expanding its research and development pipeline. London-based Solvonis, which is focused on developing innovative medicines for the treatment of addiction and mental health disorders, is focused on alcohol use disorder (AUD) and post-traumatic stress disorder (PTSD) treatments in the short-term.  The acquisition brings new therapies into its pipeline, … Continue reading BioTech acquires Toronto-based Awakn